2023-2024 Regular Session • Washington D.C. Legislature
B25-0229: Cost-Free Coverage for Prostate Cancer Screening Amendment Act of 2023
Legislative Summary
As introduced Bill 25-229 would provide cost-free coverage of one prostate-specific antigen test and digital rectal exam per year. It would also prohibit any health insurer from imposing a deductible, coinsurance, copayment, or other cost-sharing requirement for prostate cancer screening.
Bill History
3/20/2023
Introduced in Office of the Secretary
City Council
4/4/2023
Referred to Committee on Business and Economic Development
City Council
4/7/2023
Notice of Intent to Act on B25-0229 Published in the DC Register
City Council
7/28/2023
Notice of Public Hearing Published in the DC Register
City Council
8/4/2023
Notice of Public Hearing Published in the DC Register
City Council
9/28/2023
Public Hearing Held
City Council
7/2/2024
Notice of Mark-up filed in the Office of Secretary
City Council
7/3/2024
Committee Mark-up of B25-0229
City Council
7/10/2024
Committee Report Filed
City Council
9/17/2024
First Reading, CC
City Council
10/1/2024
Final Reading, CC
City Council
10/15/2024
Transmitted to Mayor, Response Due on October 29, 2024
City Council
10/24/2024
Signed by the Mayor and Enacted with Act Number A25-0591
City Council
10/25/2024
Returned from Mayor
City Council
11/1/2024
Act A25-0591 Published in DC Register Vol 71 and Page 012976
City Council
11/1/2024
Transmitted to Congress
City Council
12/17/2024
Law Number L25-0235 Effective from Dec 17, 2024
City Council
Roll Call Votes
Final Reading, CC
10/1/2024
12
Yea
0
Nay
0
Not Voting
1
Absent
Result: PASSED
First Reading, CC
9/17/2024
12
Yea
0
Nay
0
Not Voting
1
Absent
Result: PASSED
Status Information
Current Status
Passed(12/17/2024)
Chamber
City Council
Sponsors
Democrat: 11
Independent: 2
Primary Sponsor
Charles Allen
Democrat